Stability studies play an important role in inhalation medicine development, arguably more so than other delivery systems. In addition to allowing evaluation of the stability of the active drug(s), stability studies enable recommended storage conditions, retest intervals and shelf lives to be established. This short article from Teresa Iley, Director of Pharmaceutical Development and Manufacturing, Intertek Melbourn, covers an introduction to inhaled product stability considerations and testing requirements.

Meet our Expert
Teresa Iley, Director of Pharmaceutical Development and Manufacture
Teresa has nearly 25 years’ experience working within the pharmaceutical analysis and formulation development industry, with a particular focus on OINDPs. Mostly working in the pre-approval stages, Teresa’s background includes extensive experience with product and formulation development for novel and generic products, as well as method development and validation, stability studies, pharmaceutical development activities, and clinical trial manufacturing for a wide range of clients.

Please complete the form below to download the article